angiolite BTK

Sirolimus eluting peripheral stent

PRODUCT FEATURES

Stent Design

High radial force with mínimum recoil to be able to treat BTK lesions.

Specifically designed for homogeneous arterial coverage.

Coating technology

TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.

Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer.

CLINICAL SUPPORT

Angiolite BTK has demonstrated its safety and efficacy in the following clinical trial:

ANGIOLITE BTK Trial

Prospective, real-life trial in BTK lesions.

88% PP

at 6 months.

Get in touch with us

A sales representative will provide you with the requested information.

Contact with us